Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-Spain approves Pfizer shots for under-60s who got AstraZeneca first dose -El Pais

Tue, 18th May 2021 21:46

(Updates with reported approval)

MADRID, May 18 (Reuters) - Spain's public health commission
has approved a proposal by the health ministry that Spaniards
under 60 who have received a first dose of AstraZeneca's
vaccine get a second shot of the coronavirus vaccine produced by
Pfizer Inc, El Pais newspaper reported on Tuesday,
citing unnamed sources.

The proposal will affect about 1.5 million Spaniards who
received the AstraZeneca shot before the government banned it
for those aged under 60 due to blood clot concerns.

A study by the government's Carlos III Health Institute
found that mixing and matching the two drugs was both safe and
effective.
(Reporting by Victoria Waldersee; Editing by Andrei Khalip and
Peter Cooney)

Related Shares

More News
Today 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Today 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company rep...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.